News

Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss ...
Danish pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping ...
Ozempic and Wegovy maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen ... though Jorgensen had predicted a return to growth in its biggest market — the United States — in the second ...
Novo Nordisk ... of Medicine showed that people lost more weight using Wegovy competitor Zepbound, made by pharmaceutical company Eli Lilly. Eli Lilly funded the study. Novo Nordisk's share ...
Novo Nordisk (NVO) announced a new $2.2 billion ... The deal is the latest in a series focused on the pill market for obesity, deemed the next frontier in the race for the next generation of ...